Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Pharma

Imagine a future where leveraging our DNA and what we know about it prevents illness and improves care outcomes.

Co-Founder and CEO, Genome Medical, and 2020 Tom Main Health Innovation Mentorship Winner

Whoever's closest to the consumer will be the gatekeeper of the industry.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health and Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

How pharmaceutical companies can better define, measure, and deliver value to patients.

Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health and Life Sciences, Oliver Wyman

Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.

Principal, Oliver Wyman Actuarial Consulting
Global Head, Health Services, Oliver Wyman
Director, Oliver Wyman Health Innovation Center, Oliver Wyman

Insights in your inbox

Subscribe